Xenobiotic-metabolizing cytochromes P450 in human white adipose tissue: Expression and induction

Drug Metabolism and Disposition

Volumn 38, Issue 4, 2010, Pages 679-686

  Ellero, Sandrine ^a,b   Chakhtoura, Ghassan ^a   Barreau, Corinne ^c   Langouët, Sophie ^d   Benelli, Chantal ^a   Penicaud, Luc ^c   Beaune, Philippe ^a   De Waziers, Isabelle ^a  

^a INSERM   (France)

^b AGROPARISTECH   (France)

^c CNRS   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANDROSTANE RECEPTOR; CHLORPYRIFOS; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2A7; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 2R1; CYTOCHROME P450 2S1; CYTOCHROME P450 2U1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A43; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; HORMONE RECEPTOR; LINDANE; PHENOBARBITAL; PREGNANE X RECEPTOR; PROCHLORAZ; RIFAMPICIN; UNCLASSIFIED DRUG;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; LIVER BIOPSY; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE;

ADIPOCYTES, WHITE; ADIPOSE TISSUE, WHITE; ADULT; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; ENZYME INDUCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; XENOBIOTICS;

RATTUS;

EID: 77950295405     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.029249     Document Type: Article

References (41)

1. Abramoff MD, Magelhaes PJ, and Ram SJ (2004) Image Processing with ImageJ. Biophotonics Int 11:36-42.
2. Ahima RS and Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327-332.
3. Alexander DL, Eltom SE, and Jefcoate CR (1997) Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells. Cancer Res 57:4498-4506.
4. Babín M, Casado S, Chana A, Herradón B, Segner H, Tarazona JV, and Navas JM (2005) Cytochrome P4501A induction caused by the imidazole derivative Prochloraz in a rainbow trout cell line. Toxicol In Vitro 19:899-902.
5. Belloc C, Baird S, Cosme J, Lecoeur S, Gautier JC, Challine D, de Waziers I, Flinois JP, and Beaune PH (1996) Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies. Toxicology 106:207-219.
6. Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, and de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731-742.
7. Brewster DW and Matsumura F (1988) Reduction of adipose tissue lipoprotein lipase activity as a result of in vivo administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the guinea pig. Biochem Pharmacol 37:2247-2253.
8. Cho YC, Zheng W, Yamamoto M, Liu X, Hanlon PR, and Jefcoate CR (2005) Differentiation of pluripotent C3H10T1/2 cells rapidly elevates CYP1B1 through a novel process that overcomes a loss of Ah receptor. Arch Biochem Biophys 439:139-153.
9. Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, and Korczak B (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes ω- and (ω-1)-hydroxylation of fatty acids. J Biol Chem 279:6305-6314.
10. Dogra SC, Whitelaw ML, and May BK (1998) Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin Exp Pharmacol Physiol 25:1-9.
11. Elobeid MA and Allison DB (2008) Putative environmental-endocrine disruptors and obesity: a review. Curr Opin Endocrinol Diabetes Obes 15:403-408.
12. Enan E, Liu PC, and Matsumura F (1992) TCDD (2,3,7,8-tetrachlorodibenzo- P-dioxin) causes reduction in glucose uptake through glucose transporters on the plasma membrane of the guinea pig adipocyte. J Environ Sci Health B 27:495-510.
13. Feige JN, Gelman L, Rossi D, Zoete V, Métivier R, Tudor C, Anghel SI, Grosdidier A, Lathion C, Engelborghs Y, et al. (2007) The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282:19152-19166.
14. Gesta S, Lolmède K, Daviaud D, Berlan M, Bouloumié A, Lafontan M, Valet P, and Saulnier-Blache JS (2003) Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res 35:158-163.
15. Girault I, Rougier N, Chesné C, Lidereau R, Beaune P, Bieche I, and de Waziers I (2005) Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 33:1803-1810.
16. Guigal N, Seree E, Bourgarel-Rey V, and Barra Y (2000) Induction of CYP1A1 by serum independent of AhR pathway. Biochem Biophys Res Commun 267:572-576.
17. Hasler JA (1999) Pharmacogenetics of cytochromes P450. Mol Aspects Med 20:12-24, 25-137.
18. Ibarluzea Jm J, Fernández MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ, Expósito J, Lorenzo M, Torné P, Villalobos M, et al. (2004) Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 15:591-600.
19. Jimenez Torres M, Campoy Folgoso C, Cañabate Reche F, Rivas Velasco A, Cerrillo Garcia I, Mariscal Arcas M, and Olea-Serrano F (2006) Organochlorine pesticides in serum and adipose tissue of pregnant women in Southern Spain giving birth by cesarean section. Sci Total Environ 372:32-38.
20. Karlgren M, Backlund M, Johansson I, Oscarson M, and Ingelman-Sundberg M (2004) Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun 315:679-685.
21. Lafontan M and Berlan M (2003) Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 24:276-283.
22. Lakshman MR, Chirtel SJ, Chambers LL, and Coutlakis PJ (1989) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat. J Pharmacol Exp Ther 248:62-66.
23. Langouët S, Paehler A, Welti DH, Kerriguy N, Guillouzo A, and Turesky RJ (2002) Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in rat and human hepatocytes. Carcinogenesis 23:115-122.
24. Lemaire G, de Sousa G, and Rahmani R (2004) A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. Biochem Pharmacol 68:2347-2358.
25. Michalek JE, Tripathi RC, Caudill SP, and Pirkle JL (1992) Investigation of TCDD half-life heterogeneity in veterans of Operation Ranch Hand. J Toxicol Environ Health 35:29-38.
26. Müllerová D and Kopecký J (2007) White adipose tissue: storage and effector site for environmental pollutants. Physiol Res 56:375-381.
27. Nebert DW and Dalton TP (2006) The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947-960.
28. Needham D, Creedy CL, and Dawson JR (1992) The profile of rat liver enzyme induction produced by prochloraz and its major metabolites. Xenobiotica 22:283-291.
29. Park BK, Pirmohamed M, and Kitteringham NR (1995) The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacol Ther 68:385-424.
30. Parmar D, Yadav S, Dayal M, Johri A, Dhawan A, and Seth PK (2003) Effect of lindane on hepatic and brain cytochrome P450s and influence of P450 modulation in lindane induced neurotoxicity. Food Chem Toxicol 41:1077-1087.
31. Pauwels A, Covaci A, Weyler J, Delbeke L, Dhont M, De Sutter P, D'Hooghe T, and Schepens PJ (2000) Comparison of persistent organic pollutant residues in serum and adipose tissue in a female population in Belgium, 1996-1998. Arch Environ Contam Toxicol 39:265-270.
32. Petreas M, Smith D, Hurley S, Jeffrey SS, Gilliss D, and Reynolds P (2004) Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues: lessons learned from a breast cancer study. Cancer Epidemiol Biomarkers Prev 13:416-424.
33. Russo MV, Campanella L, and Avino P (2002) Determination of organophosphorus pesticide residues in human tissues by capillary gas chromatography-negative chemical ionization mass spectrometry analysis. J Chromatogr B Analyt Technol Biomed Life Sci 780:431-441.
34. Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, and Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J Acquir Immune Defic Syndr 48:20-25.
35. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, and Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979-2984.
36. Shimba S, Todoroki K, Aoyagi T, and Tezuka M (1998) Depletion of arylhydrocarbon receptor during adipose differentiation in 3T3-L1 cells. Biochem Biophys Res Commun 249:131-137.
37. Spink DC, Hayes CL, Young NR, Christou M, Sutter TR, Jefcoate CR, and Gierthy JF (1994) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 β-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51:251-258.
38. Timsit YE and Negishi M (2007) CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231-246.
39. Uemura H, Arisawa K, Hiyoshi M, Satoh H, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, and Suzuki T (2008) Associations of environmental exposure to dioxins with prevalent diabetes among general inhabitants in Japan. Environ Res 108:63-68.
40. Yoshinari K, Okino N, Sato T, Sugatani J, and Miwa M (2006) Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants. Drug Metab Dispos 34:1081-1089.
41. Yoshinari K, Sato T, Okino N, Sugatani J, and Miwa M (2004) Expression and induction of cytochromes P450 in rat white adipose tissue. J Pharmacol Exp Ther 311:147-154.